Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Blood Advances|January 10, 2022
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint studyAntony Ceraulo, Hélène Lapillonne, Meyling H Cheok, et al.
Pediatric Blood & Cancer|December 1, 2005
Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemiaFrédéric Millot, Joelle Guilhot, Brigitte Nelken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric OncologyLaurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Hemasphere|March 20, 2019
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 StudyElodie Gouache, Victoria Greze, Marion Strullu, et al.
Journal of Pediatric Hematology/Oncology|April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational surveyYves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Pediatric Blood & Cancer|November 9, 2010
CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastomaAurélien Marabelle, Etienne Merlin, Pascale Halle, et al.
Journal of Pediatric Hematology/Oncology|August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French childrenBrigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
Haematologica|March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant studyAnne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 20, 2026
Evaluation of oral health and oral health-related quality of life among childhood leukemia survivors: a pilot study in the LEA cohortAnne-Gaëlle Capitaine, Alaa Mustafa-Shawket, Julie Berbis, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Blood Advances|January 10, 2022
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint studyAntony Ceraulo, Hélène Lapillonne, Meyling H Cheok, et al.
Pediatric Blood & Cancer|December 1, 2005
Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemiaFrédéric Millot, Joelle Guilhot, Brigitte Nelken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric OncologyLaurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Hemasphere|March 20, 2019
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 StudyElodie Gouache, Victoria Greze, Marion Strullu, et al.
Journal of Pediatric Hematology/Oncology|April 9, 2008
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational surveyYves Bertrand, Françoise Mechinaud, Benoit Brethon, et al.
Pediatric Blood & Cancer|November 9, 2010
CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastomaAurélien Marabelle, Etienne Merlin, Pascale Halle, et al.
Journal of Pediatric Hematology/Oncology|August 13, 2005
Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French childrenBrigitte Bader-Meunier, Guy Leverger, Gil Tchernia, et al.
Haematologica|March 1, 2015
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant studyAnne Jourdain, Anne Auperin, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 20, 2026
Evaluation of oral health and oral health-related quality of life among childhood leukemia survivors: a pilot study in the LEA cohortAnne-Gaëlle Capitaine, Alaa Mustafa-Shawket, Julie Berbis, et al.
Pageof 20